The Emerging Risk of Peptides in Supplements LegitScript The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA Moves to Reevaluate Several Peptides American Med Spa Association Is BPC 157 Banned? Oral vs. Injectable Forms Explained